Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 94 peer-reviewed journal articles Updated
Neuroendocrinology

Acquired Hypothalamic Obesity: A Patient Guide

At a Glance

Acquired hypothalamic obesity results from damage to the brain’s hypothalamus, often after brain tumor treatment. The injury can disrupt fullness signals, increase hunger, and lower energy use, so effective care requires specialized, lifelong management—not willpower alone.

Acquired Hypothalamic Obesity (AHO) is a rare and complex medical condition that arises from physical damage to the hypothalamus, the brain’s vital command center for survival [1]. This injury most often follows life-saving treatments for brain tumors, such as craniopharyngioma, or results from radiation therapy, neurosurgery, or traumatic brain injury [2]. For many families, the diagnosis of AHO brings a sense of “whiplash”—the relief of surviving a brain tumor is quickly followed by the crisis of rapid, relentless weight gain that does not respond to traditional diet or exercise [3]. Understanding that this weight gain is the direct result of a structural neurological injury is the first step toward effective management [2].

The hypothalamus acts as the body’s internal thermostat, balancing energy intake with energy expenditure [4]. When its delicate circuits are damaged, the brain’s ability to recognize signals of fullness (satiety) is disrupted, often leading to hyperphagia—an intense, biological drive to eat that can feel uncontrollable [5]. Simultaneously, the body’s resting metabolic rate can drop significantly, causing the system to store fat more readily, altering how the body processes calories [6]. These changes are not a failure of willpower or parenting; they are physical disruptions of the brain’s regulatory machinery [1].

AHO is rarely an isolated issue; it is typically the most visible part of a broader Hypothalamic Syndrome [7]. Because the hypothalamus governs so many automatic functions, an injury can disrupt sleep-wake cycles, body temperature regulation, and the sensation of thirst [8]. Furthermore, because the hypothalamus controls the pituitary gland, AHO is frequently accompanied by hormone deficiencies that may require lifelong replacement therapy [9]. Living with AHO means managing a multi-system regulatory disruption that impacts nearly every aspect of daily life [10].

Because the underlying cause of AHO is neurological rather than behavioral, standard weight-loss advice is often insufficient [3]. Successful care requires a specialized, multidisciplinary team—led by a neuroendocrinologist—that focuses on the unique biology of the injured hypothalamus [11]. Management may involve targeted medications designed to bypass disrupted signaling pathways, the careful use of metabolic therapies, or in some cases, bariatric surgery [12][13]. Throughout this journey, the focus remains on lifelong surveillance and integrated support, empowering patients and families to navigate this chronic metabolic challenge with clarity and expert guidance [14].

In this guide

6 chapters

01

Acquired Hypothalamic Obesity: Understanding the Neurological Cause

Learn how acquired hypothalamic obesity develops after brain injury, tumor treatment, or radiation, and how doctors identify it and plan specialized care.

02

The Biology of AHO and Hypothalamic Syndrome

Learn how acquired hypothalamic obesity and hypothalamic syndrome affect hunger, energy use, thirst, temperature, sleep, and mood after hypothalamic injury.

03

The Comprehensive Workup: More Than Just Weight Loss

Learn how acquired hypothalamic obesity is evaluated, including MRI, pituitary hormone testing, metabolic, liver, and bone screening, plus lifelong monitoring.

04

Medical Management: Targeted Treatments and Safety

Learn about acquired hypothalamic obesity treatments, including setmelanotide and GLP-1 drugs, plus side effects, hormone safety, and sick-day planning.

05

Bariatric Surgery in AHO: A Powerful but Complex Tool

Learn how bariatric surgery may help acquired hypothalamic obesity, including weight loss, sleeve versus bypass, nutritional risks, and lifelong monitoring.

06

Daily Life & Safety: Managing Your Body's "Command Center"

Learn how to manage acquired hypothalamic obesity, including emergency red flags, sleep, temperature, food safety, sick-day planning, and long-term care.

Common questions in this guide

What causes acquired hypothalamic obesity?
Acquired hypothalamic obesity develops when the hypothalamus is physically damaged. This can happen after treatment for a brain tumor such as craniopharyngioma, radiation therapy, neurosurgery, or a traumatic brain injury. The damage changes brain signals that regulate hunger, fullness, and energy use.
Why can weight gain happen even when usual diet and exercise advice is followed?
The injury can weaken fullness signals, create an intense biological drive to eat, and lower the body's resting energy use. As a result, usual diet and exercise advice may not control weight as it would in other forms of obesity. This is a physical brain-related problem, not a lack of willpower.
What other health problems can occur with acquired hypothalamic obesity?
Acquired hypothalamic obesity is often part of a broader hypothalamic syndrome. Damage may disrupt sleep-wake cycles, temperature regulation, thirst, and pituitary hormone production, and hormone deficiencies may require lifelong replacement. The problems vary according to the areas affected.
Which specialists help manage acquired hypothalamic obesity?
Care is usually coordinated by a multidisciplinary team that may include a neuroendocrinologist and an obesity medicine specialist. Depending on a person's needs, the team may consider targeted medicines, metabolic therapies, hormone replacement, or bariatric surgery. The plan is based on the brain injury, hormone status, symptoms, and goals.
What does long-term care for acquired hypothalamic obesity involve?
Acquired hypothalamic obesity usually requires lifelong surveillance and integrated support because the underlying hypothalamic injury remains. Care may focus on stabilizing weight, improving energy and sleep, managing hormone deficiencies, and supporting quality of life. A multidisciplinary team can adjust care over time.

Get notified when new evidence is published on Acquired hypothalamic obesity.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (14)
  1. 1

    Acquired hypothalamic obesity: A clinical overview and update.

    Roth CL, McCormack SE

    Diabetes, obesity & metabolism 2024; (26 Suppl 2()):34-45 doi:10.1111/dom.15530.

    PMID: 38450938
  2. 2

    Diagnostic criteria for acquired hypothalamic obesity - international expert guidance document.

    Müller HL, Tanaka T, Hasegawa T, et al.

    Endocrine journal 2026; (73(2)):341-353 doi:10.1507/endocrj.EJ25-0408.

    PMID: 41224353
  3. 3

    Acquired hypothalamic dysfunction in childhood: 'what do patients need?' - an Endo-ERN survey.

    van Roessel IMAA, de Graaf JP, Biermasz NR, et al.

    Endocrine connections 2023; (12(10)).

    PMID: 37531603
  4. 4

    Hypothalamic Obesity: Prologue and Promise.

    Abuzzahab MJ, Roth CL, Shoemaker AH

    Hormone research in paediatrics 2019; (91(2)):128-136 doi:10.1159/000496564.

    PMID: 30884480
  5. 5

    Hyperphagia in craniopharyngioma- a real-world study from the international hypothalamic-pituitary brain tumors patient registry.

    Kayadjanian N, Hsu EA, Wood AM, Carson DS

    Scientific reports 2026; (16(1)).

    PMID: 41882277
  6. 6

    Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.

    Abawi O, Koster EC, Welling MS, et al.

    Frontiers in endocrinology 2022; (13()):862817 doi:10.3389/fendo.2022.862817.

    PMID: 35898454
  7. 7

    Approach to the patient with acquired hypothalamic syndrome.

    Grishman EK, McCormack SE

    The Journal of clinical endocrinology and metabolism 2026; (111(9)):2692-2703 doi:10.1210/clinem/dgag197.

    PMID: 42114110
  8. 8

    Management of Acquired Hypothalamic Dysfunction and the Hypothalamic Syndrome; It Is More Than Obesity.

    van Santen HM, Müller HL

    Endocrine reviews 2025; (46(6)):891-907 doi:10.1210/endrev/bnaf025.

    PMID: 40746184
  9. 9

    Late endocrine effects of childhood cancer.

    Rose SR, Horne VE, Howell J, et al.

    Nature reviews. Endocrinology 2016; (12(6)):319-36 doi:10.1038/nrendo.2016.45.

    PMID: 27032982
  10. 10

    Long-term quality of life and hypothalamic dysfunction after craniopharyngioma.

    Müller HL

    Journal of neuro-oncology 2025; (173(2)):233-244 doi:10.1007/s11060-025-04987-1.

    PMID: 40097882
  11. 11

    Childhood-onset Craniopharyngioma.

    Otte A, Müller HL

    The Journal of clinical endocrinology and metabolism 2021; (106(10)):e3820-e3836 doi:10.1210/clinem/dgab397.

    PMID: 34086900
  12. 12

    Pharmacologic and Non-Pharmacologic Interventions for Hypothalamic Obesity: An Updated Review.

    Zenno A, Pierce M

    Current obesity reports 2026; (15(1)).

    PMID: 42496807
  13. 13

    Efficacy and Safety of Bariatric Surgery in Acquired Hypothalamic Obesity: A Systematic Review and Individual Patient Data Meta-Analysis.

    Fessler J, Faucher P, Poitou C, Dirksen C

    Obesity reviews : an official journal of the International Association for the Study of Obesity 2026; (27(9)):e70182 doi:10.1111/obr.70182.

    PMID: 42331400
  14. 14

    Endocrine and metabolic consequences of childhood-onset craniopharyngioma during the transition age: A literature review by the TALENT study group.

    De Alcubierre D, Feola T, Puliani G, et al.

    Reviews in endocrine & metabolic disorders 2025; (26(6)):989-1008 doi:10.1007/s11154-025-09972-7.

    PMID: 40622633

This page explains acquired hypothalamic obesity for informational purposes only and does not constitute medical advice. A neuroendocrinologist and your multidisciplinary care team can interpret your symptoms and treatment history and recommend individualized care.